Suchergebnisse - "Namchuk, Mark N"

PubPharm (20)

1

Compositions and methods for modulating IL-10 immunostimulatory and anti-inflammatory properties

enthalten in: Europäisches Patentamt | 2022

von MOUSTAKAS DEMETRI T | NAMCHUK MARK N | LOSEY HEATHER C | +1

2

Advancing New Chemical Modalities into Clinical Studies

enthalten in: ACS medicinal chemistry letters | 2022

von Blanco, M. | Gardinier, K. | Namchuk, M.

3

A review of clinical efficacy data supporting emergency use authorization for COVID-19 therapeutics and lessons for future pandemics

enthalten in: Clinical and translational science | 2022

von Yoo, S. | Kim, L. | Lu, M. | +2

4

Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization

enthalten in: iScience | 2022

von Patten, J. | Keiser, P. | Morselli-Gysi, D. | +23

UpdateOf: bioRxiv. 2022 Feb 01;:. - PMID 33907750

5

Insulin and glucose metabolism with olanzapine and a combination of olanzapine and samidorphan : exploratory phase 1 results in healthy volunteers

enthalten in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | 2022

von Toledo, F. | Martin, W. | Morrow, L. | +8

6

Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivo

enthalten in: bioRxiv.org | 2022

von Patten, J. | Keiser, P. | Gysi, D. | +23

7

Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivo

enthalten in: bioRxiv : the preprint server for biology | 2022

von Patten, J. | Keiser, P. | Gysi, D. | +23

UpdateIn: iScience. 2022 Sep 16;25(9):104925. - PMID 35992305

8

A review of clinical efficacy data supporting emergency use authorization for COVID‐19 therapeutics and lessons for future pandemics

enthalten in: Clinical and Translational Science | 2022

von Yoo, S. | Kim, L. | Lu, M. | +2

9

Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease

enthalten in: bioRxiv.org | 2021

von MacDonald, E. | Frey, G. | Namchuk, M. | +3

10

A Multi-Pronged Approach Targeting SARS-CoV-2 Proteins Using Ultra-Large Virtual Screening

enthalten in: chemRxiv.org | 2021

von Gorgulla, C. | PadmanabhaDas, K. | Leigh, K. | +34